Today: 20 May 2026
Circle (CRCL) stock slips today as bitcoin heads for first annual loss since 2022
31 December 2025
2 mins read

Circle (CRCL) stock slips today as bitcoin heads for first annual loss since 2022

NEW YORK, December 31, 2025, 15:54 ET — Regular session

  • Circle shares fell about 1% in late-afternoon trade on the final session of 2025.
  • Bitcoin was lower and on track for its first annual decline since 2022, weighing on crypto-linked equities.
  • Traders are watching year-end funding conditions and the 2026 rate path that influences yields on reserve assets.

Circle Internet Group, Inc. shares slipped in afternoon trading on Wednesday, tracking a softer tone across crypto-linked assets into the final hour of the year’s last U.S. session. The stock was down 1.1% at $79.05, after trading between $78.98 and $80.37.

The move matters because Circle sits at the intersection of two markets that have been volatile into year-end: cryptocurrencies and short-term U.S. rates. Both can move quickly around thin liquidity and policy headlines.

Circle issues USDC, a so-called stablecoin — a crypto token designed to keep a steady value — and stablecoins are typically backed by low-risk assets such as U.S. dollars and Treasury bonds, a Reuters report on the company’s IPO filing said. USDC is the second-biggest stablecoin after Tether, according to CoinGecko, the report said.

Bitcoin was on track to end 2025 down more than 6% — its first annual loss since 2022 — after a year in which it hit a record above $126,000 in October and then struggled to regain footing, a separate Reuters report said. “Bitcoin increasingly exhibits the characteristics of a risk asset,” Linh Tran, a senior market analyst at XS.com, said. Reuters

Bitcoin was down 0.4% at about $87,513 in the latest trade.

Other crypto-exposed names fell more sharply. Coinbase Global was down 2.2%, while Strategy — a prominent bitcoin holder — slid 2.5%.

Rates were also in focus into year-end. U.S. short-term funding markets saw the usual turn-of-year tension, but Federal Reserve bill-buying and a record $74.6 billion draw on the New York Fed’s Standing Repo Facility helped keep cash moving through the system, market participants told Reuters.

Bond investors are heading into 2026 expecting the Fed to slow the pace of rate cuts after easing by 75 basis points in 2025, with traders pricing about 60 basis points of easing next year as of Monday, Reuters reported. For companies whose economics are tied to yields on short-dated government securities, the direction of policy expectations can matter as much as crypto prices.

Circle went public in June after pricing its U.S. initial public offering at $31 a share, raising $1.05 billion, Reuters reported at the time.

Into the start of 2026, investors will be looking for signs that demand for dollar-pegged tokens remains resilient and that trading and payments activity on crypto rails continues to expand beyond speculative flows.

They will also watch the rate backdrop. Any shift in expectations for Fed cuts — or renewed funding-market stress that pushes short-term borrowing costs higher — can change how investors model the yield earned on reserve assets that underpin stablecoins.

For now, Circle is trading like a macro proxy: sensitive to the daily swing in bitcoin and to how markets are pricing the next leg of U.S. rates.

Stock Market Today

  • LuxExperience B.V Q3 Loss Challenges Durable Profitability Narrative
    May 19, 2026, 11:01 PM EDT. LuxExperience B.V (NYSE:LUXE) reported Q3 2026 revenue of €618.5 million but posted a basic EPS loss of €0.22, wider than last year's loss of €0.06. Despite a five-year average EPS growth of 79.1%, net income swung from a €603.7 million profit in Q4 2025 to losses in recent quarters, highlighting volatility. The trailing twelve-month EPS stands at €3.46 on revenue of €2.4 billion. Shares trade at a low 1.7x price-to-earnings ratio versus 13x peers, reflecting market caution amid expected earnings decline of 78.1% annually over three years. Investors are wary of non-cash factors inflating reported profitability, questioning the sustainability of margins and cash generation. The Q3 loss challenges bullish views on consistent earnings resilience and long-term profitability for LuxExperience.

Latest articles

Wall Street Hit by Yield Jolt With Nvidia Up Next

Wall Street Hit by Yield Jolt With Nvidia Up Next

20 May 2026
U.S. stock ETFs remained lower late Tuesday after Wall Street’s main indexes fell for a third straight session, pressured by rising Treasury yields and caution ahead of Nvidia’s earnings. The SPDR S&P 500 ETF dropped 0.7% to $733.73. The 10-year Treasury yield hit 4.687%, its highest since January 2025, before easing. Nvidia shares slipped 0.7% after hours, with traders bracing for a major move post-earnings.
Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

20 May 2026
Viavi Solutions shares dropped 7.1% in after-hours trading Tuesday after the company announced a $500 million public stock offering aimed at repaying debt. The offering, unveiled just after the Nasdaq close, could add roughly 10.1 million new shares. Viavi plans to use proceeds to pay down a $450 million loan. Total debt would fall to $650 million, according to a preliminary SEC filing.
Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

20 May 2026
Analog Devices agreed to acquire Empower Semiconductor for $1.5 billion in cash, sending ADI shares up 1.36% to $419.95 in after-hours trading after closing down 1.02%. The deal, approved by both boards, is expected to close in the second half of 2026 pending regulatory review. Empower CEO Tim Phillips will continue to lead integrated voltage regulator work after the merger.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop